Discussion
An artificial intelligence (AI) tool called Capsule Networks can distinguish people with amyotrophic lateral sclerosis (ALS) from unaffected individuals, with predictive performance comparable to testing for major known ALS genes, according to a study. The large international research collaboration, which used data from more than 47,000 people across 13…